Association Bulletins

Association Bulletins provide a mechanism for publication of documents that have been approved by the Board of Directors for distribution to individual and institutional members, such as:

  • Standards that were adopted after publication of the most recent edition of Standards.
  • Statements of AABB policy intended for distribution to members.
  • Guidance, recommendations, and reports that have been developed by AABB Committees or National Office staff for distribution to members.

#20-04 - The Impact on Blood Safety of Effective Antiretroviral Medications for HIV Prevention and Treatment - 5/5/20

#20-03 - Emergent Standards to the 31st and 32nd editions of Standards for Blood Banks and Transfusion Services- 4/8/20

#20-02 - Recommendations for Providing a Safe Environment for Blood Donation During the COVID-19 Epidemic - 3/19/20

#20-01 - Association Bulletin Listings - 3/6/20


Past Association Bulletins

Listing of AABB Association Bulletins
Current as of March 6, 2020

12/13/19 #19-03      Interim Standards to the 31st edition of Standards for Blood Banks and Transfusion Services
06/26/19 #19-02 Recommendations on the Use of Group O Red Blood Cells
03/16/17 #17-02 Updated Strategies to Limit or Prevent Iron Deficiency in Blood Donors
09/28/16 #16-07 Updated Recommendations for Zika, Dengue, and Chikungunya Viruses
01/15/16 #16-02 Mitigating the Anti-CD38 Interference with Serologic Testing
12/28/15 #15-02 Transfusion-Associated Circulatory Overload (TACO)
07/18/14 #14-05 Babesiosis
07/18/14 #14-04 Clinical Recognition and Investigation of Suspected Bacterial Contamination of Platelets
01/29/14 #14-02 TRALI Risk Mitigation for Plasma and Whole Blood for Allogeneic Transfusion
07/25/13 #13-03 Updated Criteria for Donor Deferral and Blood Component Retrieval in Known or Suspected Common Source Outbreaks of Hepatitis A Virus Infection
06/27/13 #13-02 West Nile Virus Nucleic Acid Testing – Revised Recommendations
10/04/12 #12-04 Recommendations to Address Residual Risk of Bacterial Contamination of Platelets
09/21/12 #12-02 TRALI Risk Mitigation Update
11/22/10 #10-06 Information Concerning Platelet Additive Solutions
08/28/08 #08-04 Strategies to Reduce Adverse Reactions and Injuries in Younger Donors
08/30/06 #06-05 Monitoring and Preventing the Occurrence of Deviations and Near-Miss Events in Pretransfusion Testing: Mislabeling/Wrong Blood in Tube
01/24/05 #05-02 Guidance on Management of Blood and Platelet Donors with Positive or Abnormal Results on Bacterial Contamination Tests (Supplements #04-07)
10/14/04 #04-07 Actions Following an Initial Positive Test for Possible Bacterial Contamination of a Platelet Unit
08/31/04 #04-06 Reporting Donor Fatalities